National Institute of Allergy and Infectious Diseases (NIAID): Gastroenteritis trials

The registry lists 12 Gastroenteritis studies with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 1 9Phase 2 2No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Phase I Norovirus Challenge ModelCompletedNCT04174560Phase 1Results posted
• A Double-Blind Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic AreaTerminatedNCT03548064Phase 1Results posted
• NNITS-Nitazoxanide for Norovirus in Transplant Patients StudyCompletedNCT03395405Phase 2Results posted
• Phase 1 Study of dmLT ID Vaccination in Healthy AdultsCompletedNCT02531685Phase 1
• Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge StudiesCompletedNCT02473224Phase 1
• Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)WithdrawnNCT02337842Phase 1
• Safety of Sublingual dmLT for ETECCompletedNCT02052934Phase 1
• Sirolimus for Eosinophil-Associated Gastrointestinal DisordersTerminatedNCT01814059Phase 1
• Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal DisordersTerminatedNCT01212016
• Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult SubjectsCompletedNCT00654108Phase 1
• New Challenge Pool of Norwalk Virus InoculumCompletedNCT00138476Phase 1
• Omalizumab to Treat Eosinophilic GastroenteritisCompletedNCT00084097Phase 2